Jeffrey Scott Sherman - 05 Jan 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Reporting relationship: EVP, CFO and CAO
Issuer ticker: PRVA
Reported as of: 05 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jan 2022, 16:20:35 UTC
Next SEC filing: 07 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Thomas Bartrum, attorney-in-fact

Key filing fact

Jeffrey Scott Sherman filed Form 4 for Privia Health Group, Inc. (PRVA) on 07 Jan 2022.

Key facts

This page summarizes Jeffrey Scott Sherman's Form 4 filing for Privia Health Group, Inc. (PRVA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Jan 2022, 16:20.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRVA transaction

Common Stock, $0.01 par value per share

Award

Transaction value: $0
Shares: +61,307
Change %
Price: $0.000000
Shares after: 61,307
Date: 05 Jan 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRVA transaction Derivative

Stock Option (Right to Purchase)

Award

Transaction value: $0
Shares: +235,128
Change %
Price: $0.000000
Shares after: 235,128
Date: 05 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 235,128
Exercise price: $25.69
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.

Footnote F2

Represents options granted under the Issuer's 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the grant date.